HEART DEVICES MARKET MAY REACH $25 BILLION BY 2014
The U.S. market for heart devices is likely to grow by nearly 15 percent over the next 10 years, surpassing the $25 billion mark by 2014, a recent study finds.
According to a Sept. 1 report by Kalorama Information, The U.S. Market for Cardiovascular Devices, devices such as pacemakers, implantable cardioverter-defibrillators and heart stents are increasingly gaining clinical and reimbursement acceptance for a wide range of heart diseases, including congestive heart failure, arrhythmias and heart valve disease.
This report discusses the market for specific therapeutic device products for the cardiovascular market in terms of their potential in the population in the U.S. as a whole and in the 45-years-old and older subsegment of the U.S. population through 2014.
"Despite a significant slowdown in acute cardiovascular disease in the U.S. over the past few years, the same cannot be said for chronic conditions," notes Kenneth Krul, the author of the final report. "The aging of the population and the near epidemic of obesity and Type 2 diabetes even in the younger population will prolong this trend and sustain potential in this market for a long time to come."